Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
BioNTech AG
BioNTech AG
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Finance
BioNTech and Autolus announce strategic collaboration
The strategic collaboration will advance both companies' autologous CAR-T programmes towards commercialisation, pending regulatory authorisations
Manufacturing
AGC to support Pfizer-BioNTech Omicron vaccine
Plasmid DNA from AGC is already supplied as a starting material for the companies' COVID-19 vaccine
Ingredients
Pfizer and BioNTech announce early positive vaccine update
Collaboration has announced results from German Phase 1/2 COVID-19 vaccine study, including first T-Cell response data
Finance
BioNTech completes acquisition of Neon Therapeutics
Biopharmaceutical New Technologies (BioNTech) is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases
Research & Development
BioNTech and Pfizer dose first cohort of Phase I/II COVID-19 vaccine trial
The trial is the first clinical trial of a COVID-19 vaccine candidate in Germany and there are plans to initiate trials in the US upon regulatory approval
Research & Development
Sanofi and BioNTech sign cancer immunotherapy partnership
BioNTech could receive more than US$300m in development, regulatory and commercial milestones
Research & Development
BioNTech and Siemens cooperate on production of personalised cancer vaccines
Siemens will develop and construct an automated and paperless manufacturing site
Subscribe now